| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919389 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
The residual amount of normal BRCA1 seems to be sufficient for efficient DSB repair in all cell cycle phases, while the decreased DSB repair capacity of heterozygous BRCA2 mutations suggests gene dosage effects in G2.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrea Beucher, Dorothee Deckbar, Eik Schumann, Andrea Krempler, Marlis Frankenberg-Schwager, Markus Löbrich,